- Home
- VOR vs NVCT Comparison
VOR vs NVCT Comparison
Compare VOR & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | NVCT |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 813.3M | 721.2M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VOR | NVCT |
|---|---|---|
| Price | $20.65 | $19.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $45.33 | $10.00 |
| AVG Volume (30 Days) | ★ 1.5M | 482.4K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.62 | $5.55 |
| 52 Week High | $49.95 | $29.28 |
Technical Indicators
Market Signals| Indicator | VOR | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 76.17 | 57.65 |
| Support Level | $11.62 | $6.93 |
| Resistance Level | $49.95 | N/A |
| Average True Range (ATR) | 1.32 | 2.68 |
| MACD | 0.65 | 0.36 |
| Stochastic Oscillator | 81.41 | 49.35 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.